Nancy Goodman is the founder of CARGO Therapeutics. CARGO Therapeutics has raised $310M in total funding. Latest round: Series B. Based in San Carlos, CA.
Nancy Goodman, JD, is a co-founder of CARGO Therapeutics, a clinical-stage biotechnology company focused on next-generation CAR T-cell therapies for cancer patients. She is an accomplished cancer advocate and brings legal expertise to the organization, having co-founded it under its former name Syncopation Life Sciences.
Full founder directory · Investor directory · Company funding database · Fundraising library